Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125663962 | 12566396 | 2 | F | 201605 | 20160721 | 20160718 | 20160728 | EXP | BR-PFIZER INC-2016342022 | PFIZER | 85.00 | YR | F | Y | 80.00000 | KG | 20160728 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125663962 | 12566396 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | AT 1 DROP IN BOTH EYES , AT NIGHT | 20597 | EYE DROPS, SOLUTION | |||||||||
| 125663962 | 12566396 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 1 TABLET IN THE MORNING | 0 | 1 | DF | TABLET | |||||||
| 125663962 | 12566396 | 3 | C | BAMIFIX | BAMIFYLLINE HYDROCHLORIDE | 1 | Oral | 1 TABLET, 2X/DAY | 0 | 1 | DF | TABLET | BID | ||||||
| 125663962 | 12566396 | 4 | C | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 1 TABLET, 2X/DAY | 0 | 1 | DF | TABLET | BID | ||||||
| 125663962 | 12566396 | 5 | C | AAS INFANTIL | ASPIRIN | 1 | Oral | 1 TABLET, DAILY | 0 | 1 | DF | TABLET | |||||||
| 125663962 | 12566396 | 6 | C | DILTIAZEM. | DILTIAZEM | 1 | 1 TABLET, 2X/DAY | 0 | 1 | DF | TABLET | BID | |||||||
| 125663962 | 12566396 | 7 | C | RESPIDON | RISPERIDONE | 1 | Oral | 1 TABLET AT NIGHT | 0 | 1 | DF | TABLET | |||||||
| 125663962 | 12566396 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1 TABLET, DAILY | 0 | 1 | DF | TABLET | |||||||
| 125663962 | 12566396 | 9 | C | PROLOPA | BENSERAZIDELEVODOPA | 1 | Oral | 1 TABLET, 2X/DAY | 0 | 1 | DF | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125663962 | 12566396 | 1 | Eye lubrication therapy |
| 125663962 | 12566396 | 4 | Dementia Alzheimer's type |
| 125663962 | 12566396 | 5 | Coagulopathy |
| 125663962 | 12566396 | 7 | Relaxation therapy |
| 125663962 | 12566396 | 9 | Parkinson's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125663962 | 12566396 | DE |
| 125663962 | 12566396 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125663962 | 12566396 | Atrial fibrillation | |
| 125663962 | 12566396 | Chronic kidney disease | |
| 125663962 | 12566396 | General physical health deterioration | |
| 125663962 | 12566396 | Hyperkalaemia | |
| 125663962 | 12566396 | Pneumonia | |
| 125663962 | 12566396 | Product use issue | |
| 125663962 | 12566396 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125663962 | 12566396 | 1 | 2006 | 0 | ||
| 125663962 | 12566396 | 3 | 2006 | 0 | ||
| 125663962 | 12566396 | 4 | 2006 | 0 | ||
| 125663962 | 12566396 | 5 | 1996 | 0 | ||
| 125663962 | 12566396 | 6 | 2006 | 0 | ||
| 125663962 | 12566396 | 8 | 2006 | 0 | ||
| 125663962 | 12566396 | 9 | 2008 | 0 |